Current Perspectives: Obesity and Neurodegeneration - Links and Risks
Degenerative Neurological and Neuromuscular Disease · 2024-01 · Volume 13 · 111-129
DOI: 10.2147/dnnd.s388579 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Degenerative Neurological and Neuromuscular Disease, 2024-01. Verfasst von Paul J Kueck und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University of Kansas Medical Center, Kansas City, KS, 66160, USA. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 264 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: NIA NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, University of Kansas Medical Center, Kansas City, KS, 66160, USA.
- Department of Cell Biology and Physiology, University of Kansas Medical Center, Kansas City, KS, 66160, USA.
- University of Kansas Alzheimer's Disease Research Center, University of Kansas Medical Center, Kansas City, KS, 66160, USA.
- Landon Center on Aging, University of Kansas Medical Center, Kansas City, KS, 66160, USA.
ORCID-Profile: Paul J Kueck, Jill K Morris, John A Stanford
Förderung
- NIA NIH HHS
Zitieren
APA
Kueck, P. J., Morris, J. K., & Stanford, J. A. (2024). Current Perspectives: Obesity and Neurodegeneration - Links and Risks. Degenerative Neurological and Neuromuscular Disease, Volume 13, 111-129. https://doi.org/10.2147/dnnd.s388579
Vancouver
Kueck PJ, Morris JK, Stanford JA. Current Perspectives: Obesity and Neurodegeneration - Links and Risks. Degenerative Neurological and Neuromuscular Disease. 2024;Volume 13:111-129. doi:10.2147/dnnd.s388579
BibTeX
@article{Kueck2024,
author = {Kueck, Paul J and Morris, Jill K and Stanford, John A},
title = {Current Perspectives: Obesity and Neurodegeneration - Links and Risks},
journal = {Degenerative Neurological and Neuromuscular Disease},
year = {2024},
volume = {Volume 13},
pages = {111--129},
doi = {10.2147/dnnd.s388579}
}
EUVIMED